Moreover, inhibition of the EGFR/HER2 signaling axis by lapatinib blocked the expression of ABC transporter proteins, ABCB1 and ABCG2, which sensitizes MCF-7 tumor spheres to doxorubicin (229). Here, ERBB2 is linked to neoplasm.